Abstract: A gyroscopic module comprises at least one gyroscopic rotor rotatably mounted to a support, wherein the at least one gyroscopic rotor is driven by at least one first power source and at least one gimbal frame is coupled to the support of the at least one gyroscopic rotor. The gyroscopic module comprises at least one slew bearing coupled to the at least one gimbal frame to change an orientation of the at least one gyroscopic rotor, wherein the at least one slew bearing is driven by at least one second power source mounted to the at least one gimbal frame.

Abstract: A cathodic arc coating system includes alternating layers of at least one of titanium vanadium nitride (TiVN) and titanium silicon vanadium nitride (TiSiVN) disposed on a substrate; and alternating layers of titanium vanadium chromium nitride (TiVCrN) and titanium silicon vanadium nitride (TiSiVCrN) disposed on a substrate. A cathodic arc process includes a sub-hertz variable bias forming the alternating layers of alternating layers of at least one of titanium vanadium nitride (TiVN) and titanium silicon vanadium nitride (TiSiVN) disposed on a substrate; and alternating layers of titanium vanadium chromium nitride (TiVCrN) and titanium silicon vanadium nitride (TiSiVCrN) disposed on a substrate.

Abstract: A treatment device for treatment of overactive bladder conditions operates to suction to grasp and conform a mucosal tissue of the bladder wall to a portion of the tissue treatment device, and deliver energy to non-superficial target tissue at a substantially uniform depth from the mucosal tissue. The tissue treatment device incorporates multiple instruments for different functions needed to treat overactive bladder conditions. The tissue treatment device provides simplified interfaces and mechanisms for operating each of the multiple instruments in a controlled manner. Further, the tissue treatment device is configured to have a low and smooth profile that permits the tissue treatment device to be used without a tubular sheath.

Abstract: A myopia-inhibiting treatment device produces a therapeutic light that includes components of different wavelengths in a ratio of luminosities that creates a predetermined L-cone to S-cone excitation profile that slows ocular growth, thereby mitigating development of myopia. The components comprise blue light, green light, and red light. Therapeutic light may cause an L-cone to S-cone excitation ratio in a range between 1.38 and 0.05. In some implementations the therapeutic light causes a L-cone to S-cone excitation ratio of 0.74. In some implementations the luminosity of the combined light components is greater than 700 lux.

Abstract: A gyroscopic module comprises at least one gyroscopic rotor rotatably mounted to a support, wherein the at least one gyroscopic rotor is driven by at least one first power source and at least one gimbal frame is coupled to the support of the at least one gyroscopic rotor. The gyroscopic module comprises at least one slew bearing coupled to the at least one gimbal frame to change an orientation of the at least one gyroscopic rotor, wherein the at least one slew bearing is driven by at least one second power source mounted to the at least one gimbal frame.

Abstract: A system and methods for cuing visual attention using one or more sensory cues. Sensory cues, such as visual and touch cues, are used to determine an area neglected by a user and presented on a screen display to cue the user to direct his/her attention to that neglected area. Sensory cues are independent of the program content—medical image, airplane pilot simulation, security x-ray pictures—conveyed on the screen display.

Abstract: In some embodiments, the instant invention provides a chemiluminescent system, including: an activator system, including: (a) at least one first solvent, (b) at least one peroxide, (c) at least one catalyst, (d) at least one second solvent, where the at least one second solvent is selected from the group consisting of: tert-butanol, 3-methyl-3-pentanol, 2-methyl-2-butanol, ethyl 2-hydroxyisobutyrate, methyl 2-hydroxyisobutyrate, ethylene glycol, propylene glycol, ethylene glycol monomethyl ether, ethylene glycol diethyl ether, ethylene glycol monobutyl ether, ethylene glycol dibutyl ether, propylene glycol dimethyl ether, and a combination thereof; where a combination of the at least one first solvent and the at least one second solvent is present in a sufficient amount in the chemiluminescent system so as to result in the chemiluminescent system producing a light having an illuminescence between 0.1 lx and 35,000 lx at a temperature ranging from ?110 degrees Celsius to 75 degrees Celsius.

Abstract: In some embodiments, the instant invention provides a chemiluminescent system, including: an activator system, including: (a) at least one first solvent, (b) at least one peroxide, (c) at least one catalyst, (d) at least one second solvent, where the at least one second solvent is selected from the group consisting of: tert-butanol, 3-methyl-3-pentanol, 2-methyl-2-butanol, ethyl 2-hydroxyisobutyrate, methyl 2-hydroxyisobutyrate, ethylene glycol, propylene glycol, ethylene glycol monomethyl ether, ethylene glycol diethyl ether, ethylene glycol monobutyl ether, ethylene glycol dibutyl ether, propylene glycol dimethyl ether, and a combination thereof; where a combination of the at least one first solvent and the at least one second solvent is present in a sufficient amount in the chemiluminescent system so as to result in the chemiluminescent system producing a light having an illuminescence between 0.1 1× and 35,000 1× at a temperature ranging from ?110 degrees Celsius to 75 degrees Celsius.

Abstract: A myopia-inhibiting treatment device produces a therapeutic light that includes components of different wavelengths in a ratio of luminosities that creates a predetermined L-cone to S-cone excitation profile that slows ocular growth, thereby mitigating development of myopia. The components comprise blue light, green light, and red light. Therapeutic light may cause an L-cone to S-cone excitation ratio in a range between 1.38 and 0.05. In some implementations the therapeutic light causes a L-cone to S-cone excitation ratio of 0.74. In some implementations the luminosity of the combined light components is greater than 700 lux.

Abstract: The present invention relates to a sulfation method which processes a rare earth containing material. The material is roasted and exposed to a sulfur gas, then an aqueous leach to produce an insoluble metal oxide and a soluble rare earth sulfide. The insoluble and soluble material are separated utilizing a solid/liquid separator. Advantageously, the process eliminates the need for additional steps to precipitate the metal oxide in order to separate the metal from the rare earth. A system is also disclosed.

Abstract: A system and methods for cuing visual attention using one or more sensory cues. Sensory cues, such as visual and touch cues, are used to determine an area neglected by a user and presented on a screen display to cue the user to direct his/her attention to that neglected area. Sensory cues are independent of the program content—medical image, airplane pilot simulation, security x-ray pictures—conveyed on the screen display.

Abstract: A retractable connector assembly for establishing an electrical connection to a power bus bar from an electrical device is disclosed. The retractable connector assembly includes a frame plate and a sled. The sled has a rack and a connector assembly having an electrical contact. The sled has an extended position and a retracted position relative to the frame plate. A spur gear is mounted on the frame plate. The spur gear engages the rack to move the sled between the retracted position and the extended position when the spur gear is rotated. The electrical contact creates an electrical connection with the power bus bar when the sled is in the extended position but not in the retracted position. Safety interlocks and indicia can be provided for the connector assembly.

Abstract: Circuit and associated methods for dynamically adjusting the spectral content of an audio signal, which increases the harmonic content through the systematic introduction of amplitude asymmetry. In one embodiment, the method comprises a spectral modification of an analog audio signal in which the high-frequency content is reduced as a function of the signal amplitude and spectral distribution. The audio signal is subjected to a complementary pre-emphasis and de-emphasis of the high frequencies.

Abstract: A retractable connector assembly for establishing an electrical connection to a power bus bar from an electrical device is disclosed. The retractable connector assembly includes a frame plate and a sled. The sled has a rack and a connector assembly having an electrical contact. The sled has an extended position and a retracted position relative to the frame plate. A spur gear is mounted on the frame plate. The spur gear engages the rack to move the sled between the retracted position and the extended position when the spur gear is rotated. The electrical contact creates an electrical connection with the power bus bar when the sled is in the extended position but not in the retracted position. Safety interlocks and indicia can be provided for the connector assembly.

Abstract: File folders are provided having bent hangers from which a receptacle is suspended so that the top of the receptacle is beneath a rail-engaging portion of the hangers and/or beneath a top of the rail or other supporting structure of office storage equipment. The hangers of the file folder may also be collapsible for use outside the office storage equipment. The hangers may also have a grip, or handle, for removal of the file folder from the office storage equipment.